( NASDAQ-NMS:AMRI )

News from AMRI A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 02, 2017, 08:00 ET AMRI Names Joseph D. Sangregorio as Senior Vice President and Chief Human Resources Officer

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes...


Sep 12, 2017, 08:00 ET AMRI Names Stephen Leonard as Senior Vice President, Head of Global Operations

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes...


Aug 31, 2017, 12:30 ET AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR

Albany Molecular Research, Inc. (NASDAQ: AMRI), a global contract research, development and manufacturing organization working with the life...


Jun 29, 2017, 08:00 ET AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI

Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life...


Jun 06, 2017, 07:30 ET AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash

Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life...


Jun 02, 2017, 09:15 ET AMRI to Present at Jefferies Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the...


May 09, 2017, 07:30 ET AMRI Announces First Quarter 2017 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook...


May 02, 2017, 08:00 ET AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services

AMRI (NASDAQ: AMRI) today announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences...


Apr 26, 2017, 08:00 ET SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing

WEST LAFAYETTE, Ind., April 26, 2017 /PRNewswire/ -- SSCI, a division of Albany Molecular Research Inc. (AMRI), has been recognized by Global...


Apr 25, 2017, 08:00 ET AMRI Schedules First Quarter 2017 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2017 financial results before the opening of the market on Tuesday, May 9, 2017....


Mar 22, 2017, 08:00 ET AMRI Receives CMO Leadership Awards for Excellence

AMRI (NASDAQ: AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences...


Mar 03, 2017, 08:00 ET AMRI to Present at Barclays Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the...


Feb 21, 2017, 08:05 ET AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products

AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc....


Feb 21, 2017, 07:28 ET AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided an...


Feb 15, 2017, 08:00 ET AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday,...


Feb 07, 2017, 08:00 ET AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery

AMRI (NASDAQ: AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered...


Dec 13, 2016, 08:00 ET AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


Nov 29, 2016, 07:45 ET AMRI Announces API Supply Agreement with Shire

AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing,...


Nov 14, 2016, 07:45 ET AMRI to Present Two Posters at AAPS 2016

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual...


Nov 08, 2016, 07:30 ET AMRI Announces Third Quarter 2016 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2016 and reiterated its outlook for...


Oct 20, 2016, 08:00 ET AMRI Schedules Third Quarter 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2016 financial results before the opening of the market on Tuesday, November 8,...


Oct 03, 2016, 09:27 ET AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

 AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio...


Aug 30, 2016, 08:00 ET AMRI CEO to Present at Morgan Stanley Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


Aug 24, 2016, 08:00 ET AMRI CEO to Present at Baird 2016 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Aug 23, 2016, 16:05 ET AMRI Licenses CRISPR-Cas9 Gene Editing Technology

 AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and...